Home > Press > Tegal Corporation Reports First Quarter Fiscal 2009 Financial Results
Abstract:
Tegal Corporation (Nasdaq: TGAL), a leading designer and manufacturer of plasma etch and deposition systems used in the production of integrated circuits and nanotechnology devices, today announced financial results for the First Quarter Fiscal Year 2009, which ended June 30, 2008. Senior management will conduct an investor conference call to discuss these results and the company's financial outlook in more detail today at 2 p.m. Pacific Time, Wednesday, August 13, 2008. More information about the conference call is provided below.
First Quarter Highlights
-- The Company shipped an advanced etch system to SVTC
Technologies, located in San Jose. SVTC operates a leading
process development foundry for the rapidly growing novel
memory and transistor market along with the MEMS/MOEMS,
photovoltaics, biotechnology, image sensors and high-voltage
markets. Tegal also announced, as part of the plasma etch
equipment order, that Tegal and SVTC are working together on
process recipe development for these applications.
-- The Company shipped an Endeavor AT PVD cluster tool from a
leading global manufacturer of discrete and analog
semiconductor components for the consumer electronics,
industrial, and automotive markets. The Endeavor AT PVD system
will be used by Tegal's customer for backside metallization
applications on thin wafers at the customer's domestic,
ISO-certified wafer fab.
-- In addition, the Company announced orders for a 901ACS plasma
etch tool, and additional orders for Tegal 900 Series ACS
upgrades, from a leading maker of BioMEMS-based medical
testing products.
Financial Results
Revenues for the first quarter of fiscal 2009 were $4.7 million, an increase of 3% from the $4.6 million for the same quarter last year. Tegal reported a net loss of ($0.8) million, or ($0.11) per share, for the quarter, compared to a net loss of ($0.6) million, or ($0.09) per share in the comparable quarter one year ago.
Gross profits for the first quarter of fiscal 2009 were 49.2% compared to 35.3% in the same quarter one year ago and 50.6% from the previous quarter.
Operating losses for the first quarter were ($1.0) million, including approximately $0.5 million of non-cash charges. This was an improvement compared to the ($1.4) million loss in the same period last year, which included $0.6 million of non-cash charges. Operating income in the previous quarter was $0.8 million. Included in the $0.8 million of income for the previous quarter was approximately $0.4 million of non cash charges.
Cash at the end of the fiscal first quarter of 2009 was $18.2 million, a $1.1 million decrease from the end of the March quarter. Over the same 3 month period, accounts payable and accrued liabilities decreased by $1.0. Accounts receivable also decreased by $0.8 million.
"Our results for this quarter were below our expectations, as several projects in which we were engaged were either postponed or cancelled. The current environment in semiconductor capital equipment is challenging - more so than any other time since the beginning of the decade," said Thomas Mika, President & CEO of Tegal. "However, the shipment of an advanced 6500 etch system to SVTC was a big plus for the quarter. It is a high visibility installation and we have already generated several sales leads from SVTC development customers. In addition, we are completing our Compact(TM)360NLD system for shipment later this month, and the official launch of the product at Semicon West in mid-July was a great success. While we expect the environment to remain challenging in the near future, we have a strong cash position and believe we will sustain or improve our market position."
Investor Conference Call
Tegal Corporation will discuss these results and further details of its first quarter of fiscal 2009 during a conference call today, August 13, 2008, at 5:00 p.m. EDT / 2:00 p.m. PDT. The call is open to all interested investors. The call-in numbers are (866) 543-6405 or (617) 213-8897. For either dial-in number, Investors should reference passcode: 96260153. A digital recording will be made available two hours after the completion of the conference call, and it will be accessible through midnight on Thursday, August 21, 2008. To access, investors should dial (888) 286-8010 or (617) 801-6888 and enter passcode: 61883987. The conference call also will be available online via the Investor Section of the Company's website at: www.tegal.com. An online replay of the teleconference, along with a copy of the Company's earnings release, will also be available on the Company's website.
Annual Meeting
The Company will hold its Annual Meeting at 10:00 a.m. PDT on Tuesday, September 23, 2008 at its headquarters located at 2201 South McDowell Blvd., Petaluma, California. Stockholders of record as of July 25, 2008 are invited to attend.
Safe Harbor Statement
Except for historical information, matters discussed in this news release contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements, which are based on assumptions and describe our future plans, strategies and expectations, are generally identifiable by the use of the words "anticipate," "believe," "estimate," "expect," "intend," "project" or similar expressions. These forward-looking statements are subject to risks, uncertainties and assumptions about the Company including, but not limited to industry conditions, economic conditions, acceptance of new technologies and market acceptance of the Company's products and services. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements in this paragraph. For a further discussion of these risks and uncertainties, please refer to the Company's periodic filings with the Securities and Exchange Commission.
####
About Tegal Corporation
Tegal provides process and equipment solutions to leading edge suppliers of advanced semiconductor and nanotechnology devices. Incorporating unique, patented etch and deposition technologies, Tegal's system solutions are backed by over 35 years of advanced development and over 100 patents. Some examples of devices enabled by Tegal technology are energy efficient memories found in portable computers, cellphones, PDAs and RFID applications; megapixel imaging chips used in digital and cellphone cameras; power amplifiers for portable handsets and wireless networking gear; and MEMS devices like accelerometers for automotive airbags, microfluidic control devices for ink jet printers; and laboratory-on-a-chip medical test kits.
TEGAL CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (In thousands, except share data) June 30 March 31 2008 2008 --------- --------- ASSETS Current assets: Cash and cash equivalents $ 18,181 $ 19,271 Accounts receivable, net of allowances for sales returns and doubtful accounts of $227 and $191 at June 30, 2008 and March 31, 2008, respectively 5,994 6,758 Inventories, net 11,009 11,056 Prepaid expenses and other current assets 794 788 --------- --------- Total current assets 36,217 37,873 Property and equipment, net 1,233 1,213 Intangible assets, net 842 903 Other assets 84 90 --------- --------- Total assets $ 38,377 $ 40,079 ========= ========= LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Notes payable and bank lines of credit $ 8 $ 14 Accounts payable 896 1,469 Accrued product warranty 1,315 1,770 Deferred revenue 383 252 Accrued expenses and other current liabilities 3,244 3,644 --------- --------- Total current liabilities 5,669 7,149 --------- --------- Total long term liabilities -- -- --------- --------- Total liabilities 5,669 7,149 --------- --------- Commitments and contingencies (Note 7) Stockholders' equity: Preferred stock; $0.01 par value; 5,000,000 shares authorized; none issued and outstanding -- -- Common stock; $0.01 par value; 200,000,000 shares authorized; 7,263,473 and 7,242,736 shares issued and outstanding at June 30, 2008 and March 31, 2008, respectively 73 72 Additional paid-in capital 123,898 123,567 Accumulated other comprehensive income (loss) (448) (446) Accumulated deficit (90,055) (90,263) --------- --------- Total stockholders' equity 32,709 32,930 --------- --------- Total liabilities and stockholders' equity $ 38,377 $ 40,079 ========= ========= TEGAL CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (In thousands, except per share data) Three Months Ended June 30, ------------------- 2008 2007 --------- --------- Revenue $ 4,729 $ 4,598 Cost of revenue 2,402 2,977 --------- --------- Gross profit 2,327 1,621 --------- --------- Operating expenses: Research and development expenses 1,136 778 Sales and marketing expenses 843 1,006 General and administrative expenses 1,330 1,203 --------- --------- Total operating expenses 3,309 2,987 --------- --------- Operating loss (982) (1,366) Other income (expense), net 190 728 --------- --------- Net loss $ (792) $ (638) ========= ========= Net loss per share, basic and diluted $ (0.11) $ (0.09) Shares used in per share computation: Basic and diluted 7,177 7,110
For more information, please click here
Contacts:
Tegal Corporation
Christine Hergenrother
707/763-5600 (VP and CFO)
or
The Blueshirt Group
Gina DeBoutez or Chris Danne
415/217-7722
Copyright © Business Wire 2008
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Chip Technology
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||